ASX:NSB (Australia)
Â
Ordinary Shares
A$
0.060
(0%)
Jul 31
Business Description
Neuroscientific Biopharmaceuticals Ltd
ISIN : AU0000012973
Share Class Description:
ASX:NSB: Ordinary SharesDescription
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and treatments for neurodegenerative diseases through preclinical studies of patented technologies.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.99 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 45.2 | |||||
3-Year EPS without NRI Growth Rate | 43.7 | |||||
3-Year FCF Growth Rate | 50 | |||||
3-Year Book Growth Rate | 10.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 29.24 | |||||
9-Day RSI | 38.23 | |||||
14-Day RSI | 40.29 | |||||
3-1 Month Momentum % | -43.81 | |||||
6-1 Month Momentum % | -57.86 | |||||
12-1 Month Momentum % | -74.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 31.6 | |||||
Quick Ratio | 31.6 | |||||
Cash Ratio | 30.56 | |||||
Days Sales Outstanding | 138.88 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -1058.49 | |||||
Net Margin % | -999.06 | |||||
EBITDA Margin % | -788.37 | |||||
FCF Margin % | -436.79 | |||||
OCF Margin % | -436.79 | |||||
ROE % | -24.92 | |||||
ROA % | -24.67 | |||||
ROIC % | -50.06 | |||||
3-Year ROIIC % | 92.57 | |||||
ROC (Joel Greenblatt) % | -6070.7 | |||||
ROCE % | -24.92 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 60 | |||||
PB Ratio | 1.22 | |||||
Price-to-Tangible-Book | 3 | |||||
EV-to-EBIT | -5.36 | |||||
EV-to-EBITDA | -6.79 | |||||
EV-to-Revenue | 53.54 | |||||
EV-to-FCF | -12.26 | |||||
| Price-to-Net-Current-Asset-Value | 3 | |||||
| Price-to-Net-Cash | 3 | |||||
Earnings Yield (Greenblatt) % | -18.66 | |||||
FCF Yield % | -5.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Neuroscientific Biopharmaceuticals Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.318 | ||
| EPS (TTM) (A$) | -0.015 | ||
| Beta | 1.5115 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.68 | ||
| Volatility % | 62.44 | ||
| 14-Day RSI | 40.29 | ||
| 14-Day ATR (A$) | 0.003474 | ||
| 20-Day SMA (A$) | 0.06435 | ||
| 12-1 Month Momentum % | -74.89 | ||
| 52-Week Range (A$) | 0.055 - 0.25 | ||
| Shares Outstanding (Mil) | 389.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neuroscientific Biopharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neuroscientific Biopharmaceuticals Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Neuroscientific Biopharmaceuticals Ltd Frequently Asked Questions
What is Neuroscientific Biopharmaceuticals Ltd(ASX:NSB)'s stock price today?
The current price of ASX:NSB is A$0.06. The 52 week high of ASX:NSB is A$0.25 and 52 week low is A$0.06.
When is next earnings date of Neuroscientific Biopharmaceuticals Ltd(ASX:NSB)?
The next earnings date of Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) is .
Does Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) pay dividends? If so, how much?
Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Neuroscientific Biopharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers